telmisartan has been researched along with 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammazzalorso, A; Amoia, P; Amoroso, R; Maccallini, C | 1 |
1 review(s) available for telmisartan and 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid
| Article | Year |
|---|---|
Multitarget PPARĪ³ agonists as innovative modulators of the metabolic syndrome.
Topics: Animals; Antihypertensive Agents; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Humans; Hypertension; Hypoglycemic Agents; Metabolic Syndrome; Molecular Structure; PPAR gamma; Structure-Activity Relationship | 2019 |